ID

35189

Description

Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the subjects current medical conditions and should be filled out at visit 1.

Lien

https://clinicaltrials.gov/ct2/show/NCT00992160

Mots-clés

Versions (3)

1. 23/02/2019 23/02/2019 -
2. 01/03/2019 01/03/2019 -
3. 10/11/2019 10/11/2019 -

Détendeur de droits

GlaxoSmithKline

Téléchargé le

23 février 2019

DOI

Pour une demande vous connecter.

Licence